Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCTT11 in Thyroid Eye Disease
NCT06769984Phase 2Not yet recruiting
- Sponsor
- Sinocelltech Group Limited
- Start
- Feb 2025
- Primary completion
- Jun 2026
01
Overview
A Phase 2 trial of SCTT11 in thyroid eye disease (TED), sponsored by Sinocelltech Group Limited. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
SCTT11
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT06769984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06769984.